Market Overview:
The global allergic rhinitis market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of allergic rhinitis, rising awareness about available treatment options, and growing demand for over-the-counter (OTC) drugs. Based on type, the global allergic rhinitis market can be segmented into Rx and OTC drugs. The Rx drug segment is expected to account for a larger share of the global market than the OTC drug segment during the forecast period. This can be attributed to factors such as high cost of prescription drugs and increasing preference for self-medication among patients with allergies. However, growth in the OTC drug segment is expected to outpace that of the Rx drug segment during the forecast period due to rising awareness about available treatment options and growing demand for affordable medications. Based on application,the global allergic rhinitis market can be divided into hospital pharmacy, retail pharmacy, and online pharmacy segments.
Product Definition:
Allergic rhinitis is a condition in which the lining of the nose becomes inflamed and swells as a result of an allergic reaction. It can cause sneezing, coughing, itchy eyes, a runny nose, and congestion.
Rx:
Rx is short for prescription. Allergy rhinitis is a type of allergic disorder caused by abnormal response of the immune system to substances present in the environment, usually odorless and invisible to common human eye like tree, grass or flower pollen. The most common symptoms include congestion or itchiness in nose, itchy eyes and sneezing. Other symptoms may include swelling of eyelids, rash on skin around mouth and/or feet along with diarrhea.
OTC:
OTC stands for Over-the-Counter and it's the most common type of medicines used for the treatment of allergies, colds, insomnia, and other health problems. OTC drugs are easily available to consumers without a prescription. According to FDA guidelines; all OTC products that are available in capsule or tablet form must have the active ingredient listed on the product label in order to be sold as over-the-counter (OTC) products.
Application Insights:
The others segment held the largest market share of more than 50.0% in 2017 and is anticipated to witness significant growth over the forecast period. The others segment includes allergic rhinitis with nasal congestion and without nasal symptoms, which are prevalent among individuals who have allergies to various substances such as dust, mold, animal dander or hair, food proteins like nuts and eggs, latex products or certain drugs.
The hospital-based pharmacy was the largest application of global allergic rhinitis market in 2017 owing to high prevalence of patients admitted due to colds/respiratory infections at hospitals across the world. In addition, factors including increasing number of travelers' diarrhea cases across different regions coupled with rising awareness about OTC medicines that can be purchased from local stores are expected to drive demand for anti-allergy drugs from hospital pharmacies over the forecast period.
Regional Analysis:
Europe was the largest regional market in 2017 owing to high prevalence of allergic rhinitis and increasing awareness about various treatment options. In addition, growing presence of key manufacturers in countries such as Germany, U.K., France and Russia is expected to drive the product demand over the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions due to rising geriatric population, improving economic conditions especially in India & China and increasing healthcare expenditure levels. Growing awareness about different treatment options for allergic rhinitis will also contribute toward regional growth over the forecast period.
Growth Factors:
- Increasing prevalence of allergic rhinitis
- Growing awareness about allergic rhinitis and its treatment options
- Rising disposable income of people in developing countries
- Availability of effective over-the-counter medications for allergic rhinitis
- Increased research and development activities for new therapies for allergic rhinitis
Scope Of The Report
Report Attributes
Report Details
Report Title
Allergic Rhinitis Market Research Report
By Type
Rx, OTC
By Application
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Companies
Johnson & Johnson, Sanofi, GSK, Bayer, Merck, Mylan, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Allergic Rhinitis Market Report Segments:
The global Allergic Rhinitis market is segmented on the basis of:
Types
Rx, OTC
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Sanofi
- GSK
- Bayer
- Merck
- Mylan
- Johnson & Johnson
Highlights of The Allergic Rhinitis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rx
- OTC
- By Application:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Allergic Rhinitis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Allergic rhinitis is an inflammation of the nasal passages and sinuses caused by a reaction to pollen, dust, pet dander, or other allergens. Symptoms can include sneezing, runny nose, itchy eyes and ears, and difficulty breathing. Allergic rhinitis is most common in people who are sensitive to pollens from grasses or trees.
Some of the key players operating in the allergic rhinitis market are Johnson & Johnson, Sanofi, GSK, Bayer, Merck, Mylan, Johnson & Johnson.
The allergic rhinitis market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Allergic Rhinitis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Allergic Rhinitis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Allergic Rhinitis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Allergic Rhinitis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Allergic Rhinitis Market Size & Forecast, 2020-2028
4.5.1 Allergic Rhinitis Market Size and Y-o-Y Growth
4.5.2 Allergic Rhinitis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Rx
5.2.2 OTC
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Pharmacy
6.2.3 Online Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Allergic Rhinitis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Allergic Rhinitis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Rx
9.6.2 OTC
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Pharmacy
9.10.3 Online Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Rx
10.6.2 OTC
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Pharmacy
10.10.3 Online Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Rx
11.6.2 OTC
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Pharmacy
11.10.3 Online Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Rx
12.6.2 OTC
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Pharmacy
12.10.3 Online Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Rx
13.6.2 OTC
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Pharmacy
13.10.3 Online Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Allergic Rhinitis Market: Competitive Dashboard
14.2 Global Allergic Rhinitis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Sanofi
14.3.3 GSK
14.3.4 Bayer
14.3.5 Merck
14.3.6 Mylan
14.3.7 Johnson & Johnson
